Theme: Advances in Diagnostics for Stroke and Neurological disorder

Stroke Summit 2023

Stroke Summit 2023

We are delighted to extend an invitation on behalf of the Conference Series to all participants from across the world to the "Stroke Summit 2023" which will be held in London UK. on October 16–17, 2023.

The goal of the '10th International Conference on Stroke and Neurological Disorders' is to promote innovative treatments for stroke and other neurological conditions that will advance neurosurgery and neuroscience. "Advances in Diagnostics for Stroke and Neurological disorder" is the concept that will guide the conference's planning. Our mission is to bring together eminent academics from across the world who is experts in the fields of brain and neurology in order to share their positive experiences with various stroke and neurological diseases treatment options.

Scope and Importance:

Today, the majority of nations in the world offer access to medical education. A full range of information and access to education in the fields of diagnosis, prevention, and treatment are provided by the stroke and neurological disorders conference, which serves as a platform to encourage people to take preventive measures and control of their health against neurological disorders.

The Stroke Summit 2023 will honour distinguished awards for:

 • Young scientists

 • Young investigators,

 • Trainees, junior professors,

• Post-Graduate students,

 • Post-doctoral fellows,

The 2023 Stroke Summit aids in recognising their exceptional contribution to the conference's subject. By bringing together professionals to exchange and share their expertise on all parts of neurology and neuroscience, the Young Scientist Awards make every effort to provide early career academicians with a solid professional development opportunity.

Prizes for outstanding masters, doctoral and post-doctoral thesis work will be given at the Stroke Summit in 2023 by the Young Researcher Forum. At the Stroke Summit 2023, there can be no more than 25 presentations.

Advantages of YRF Registration,

• A certificate of achievement and souvenir for the winners of the Young Scientist Award.

• The Stroke Summit 2023 offers the ideal platform for oral presentations of your findings.

• Get knowledge about the newest technology for job advancement through networking.

Why Provide established senior researchers and researchers from other countries the chance to collaborate on research in the area of neuroscience.

Young researchers have a wonderful opportunity to learn about new research fields and broaden their understanding of the field.

Reasons To Go:

The conference's objective is to create translational neuroscience initiatives that will help people comprehend how the field has evolved over the previous few years and how treatment approaches have advanced.

Patient care, innovation, digital neurology, and research are the four main objectives of the conference. In the quickly evolving fields of neuroscience and neurology, innovative technologies are changing our comprehension of and approach to treating neurological issues.

Stroke Summit 2022's theme is "Shape up a healthier and disorder-free world," highlighting the significance of cooperation and communication among people in many professions.

The networking possibilities, breakout sessions, speakers, and hands-on training during the congress are unmatched. However, an honorarium is just a stopping station for you to meet up with regional groups, teams, experts, and exhibitors in person so that you may expand your knowledge, exchange ideas, and enjoy yourself in a stunning environment.

Students and recent graduates will be encouraged to submit their original research for publication in Conference Series Journals by the conference's student poster competition and young researcher’s forum. All accepted abstracts will be displayed in poster sessions during the conference. The opportunity to submit an electronic poster with an abstract that is posted online with a DOI number is available to all participants who are unable to attend the conference.

Target audience:

  • 4,444 doctors, young researchers, faculties of medicine, societies and associations fighting against pediatric cancer, medical device manufacturing companies, healthcare professionals and managers of healthcare companies, pharmaceutical companies (design and discovery drugs), the neuro and central nervous system drug industry, neuroscience associations and foundations, university professors and students studying neurological disorders and stroke, and researchers who use neurophysiological techniques and knowledge to diagnose and manage neurological disorders in patients with neurological disorders.
  • Our Congress offers new ideas, beliefs, technologies and strategies that legitimately influence the way we work together. No other conference offers such an array of keynote speakers, high profile attendees and engaging content.

Highlights of the 2023 Stroke Summit include:

  • The event will bring together eminent researchers, as well as business visionaries and speculators in this dynamic field, to discuss honest opinions and viewpoints. The event is often attended by high-level decision makers from many industries, many of whom are familiar with our former speakers, and prominent speakers, leading researchers, and professionals from around the world are asked to share their knowledge and experiences. Due to the correct attitudes towards meeting new people, this generates a relaxed and easy-going setting.
  • The confusion in the nervous system is a neurological disorder; it may also manifest as other electrical or biochemical abnormalities in the spine, brain, or another nerve. A variety of manifestations may result from this.

We can't wait to meet you and invite you to take part in our fascinating conference. Please allow us the chance to meet and greet you in one of the most stunning urban areas in the world. 

Market Analysis:

The market for stroke management is expected to reach $36,756 million by 2023, growing at a CAGR of 7.1% from its 2016 revenue of $22,581 million (2017-2023).

When the brain's blood flow is interrupted and the brain cells start to degrade, a stroke is a significant medical emergency that can occur. The incidence and prevalence of chronic diseases are on the rise, which is what is driving the industry.

In addition, an ageing population that is more susceptible to strokes, patients' increased rates of diabetes and tobacco use are all driving factors in the market. The high cost of therapy and governmental limitations on the approval of cutting-edge devices and drugs are predicted to restrain market expansion, nevertheless.

The industry outlook is improving as cases of cardiovascular disease (CVD) rise globally. The CDC estimates that in 2020, heart disease caused 1 in 5 deaths in the U.S., killing close to 697,000 individuals.

Over 17.9 million people die from CVDs each year, which the WHO estimates to be the cause of approximately 31% of mortality globally. Heart disease increases the risk of coronary artery disease and stroke, both of which are commonly deadly or result in other health problems that impede function. So, there is a sizable market for effective stroke care products and services.

Review of the market segments:

The global market for stroke management is divided into two types: diagnostic and medical. Diagnostics now holds the greatest market share and is predicted to expand at the fastest rate throughout the projected period.

The market is being driven by the rising use of diagnostic techniques, such as MRIs, CT scans, and other techniques for the early diagnosis of strokes. Due to the rising number of ischemic stroke and trauma cases, ischemic stroke accounted for the biggest market share by application..

Review of the four geographical segments:

 The stroke management market globally is comprised of North America, Europe, Asia-Pacific, and LAMEA. North America, then Europe, accounted for the greatest portion of the global market in 2016.

On the other side, it is projected that Asia would have the quickest rate of regional expansion throughout the length of the analysis. Together with greater government spending on R&D and the creation of better healthcare facilities, chronic illnesses and stroke are becoming more common. These are the main driving forces behind the expansion of this market.

The region of Asia-Pacific is predicted to have the most potential for expansion due to the concentration of key businesses in developing markets and improvements in the infrastructure for providing Healthcare

Europe's mortality rate from stroke,

Three specific types of cerebrovascular disease—ischemic stroke, haemorrhagic stroke, and subarachnoid haemorrhage (SAH), in which bleeding occurs between the brain and surrounding membrane—are studied to determine mortality trends in Europe over a 37-year period between 1980 and 2016. The data comes from the World Health Organization (WHO)..

High cost procedures for stroke care could stymie market growth:

Stroke is one of the most often identified causes of neurological disorders and patient disability. It is therefore often believed to result in a heavy financial burden, which could harm industry statistics.

According to predictions, stroke-related medical costs will have topped USD 240 billion globally by the end of 2030. The rising preference for mechanical thrombectomy over medical therapy, which requires an interventional procedure and high expenses for imaging tests, medical equipment, and angiography suite time, may be a key barrier to market growth

Partially Driving Demand from Hospital End Users are Reimbursement Policies:

According to end use, the stroke management market is divided into ambulatory surgical centres, diagnostic centres, hospitals, and others. The market share of the healthcare sector will surpass 39% by 2022.

The segment is anticipated to develop significantly as a result of rising hospital admissions, which are in turn being pushed by more advantageous reimbursement policies for treatments received in hospitals.

The American Hospital Association predicts that in 2022, there will be more than 33.3 million heart attacks and strokes hospitalised in the US.

Funding from the Public and Commercial Sectors Will Rise to Support the Asia-Pacific Stroke Management Market:

By 2032, it is anticipated that the market share for stroke management in Asia-Pacific would approach USD 17 billion. The expansion of the regional market share will be fuelled by the rising financial support given to initiatives by both public and private organisations to increase public awareness of cardiovascular disease. The increase in the

Segment’s success will also depend on how hard the key regional industry players work to expand their market share in Asia Pacific's developing nations.

The leading competitors in the stroke management market are GE Healthcare, Boston Scientific Corporation, Medtronic, Johnson & Johnson, Penumbra, Inc., and other well-known businesses. These organisations aim to reshape the market landscape for stroke management through mergers and acquisitions. Many companies are focusing more on mergers and acquisitions to build up larger product portfolios and production capacities.

For instance, Oscar, Inc., a top business in the industry, was acquired by Integer Holdings Corporation in December 2021, a pioneer in the field of complex medical device design. As a result of the arrangement, Integer should be able to enhance production capacity while also expanding its range of cardio and neuro stimulation devices.COVID-19's effects on market trends for stroke management:

The COVID-19 pandemic had a major impact on global trade; certain countries reported a decrease in the incidence of acute stroke victims. A significant decrease in stroke consultations and rates of reperfusion therapy, particularly thrombolysis, was also observed as a result of government recommendations to lower COVID-19.

The stroke management market research report offers a thorough overview of the industry together with revenue projections and estimates in USD for the following market categories from 2016 to 2027. It also expands the range of cardiovascular and neuro stimulation devices available.

Type-wise segmented:

  • Ischemic
  • Haemorrhagic
  • Transient Ischemic Attack (TIA)

 Product-wise segmented:

  • Diagnostic Devices
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography Scan (CT scan)
    • Electrocardiography
  • Therapeutic Devices
  • Stent retriever
  • Surgical clips
  • Embolic coils


  • Hospitals
  • Ambulatory Surgery Centres
  • Diagnostic Centres


Above mentioned information provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Others
  • Japan
  • China
  • India
  • Australia
  • Others
  • Brazil
  • Mexico
  • Others
  • South Africa
  • Saudi Arabia
  • UAE
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The "10th International conference on Stroke and Neurological Disease" was presented by Conference Series in London, UK on August 8–9, 2022. The conferences, which had as their topics "Innovative methods to overcome Stroke & inspire new research in neurological illnesses," were a big success and featured eminent keynote speakers from numerous reputable companies and universities who addressed the audience.

Conference Series would like to express its sincere gratitude to all of the honourable guests and keynote speakers of the ‘’10th International conference on Stroke and Neurological Disease" We would like to express our sincere appreciation to all of the distinguished attendees and keynote speakers of Stroke Conference 2022.

The Stroke Summit 2022 Committee would like to express its sincere gratitude to all of the distinguished guests and keynote speakers, including Holly Kooi from Ushine London UK; Florian Trummer from Hospital of the Brothers of St. John of God London UK; and Sejran Abdushi from UBT- Hiroshima.

The Stroke Summit 2022 organising committee, keynote speakers, plenary speakers, chairs and co-chairs, young researchers, and other attendees were honoured by Conference Series for their contributions to the conference's success.

We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events.

The most recent challenges and trends in the multidisciplinary Stroke Summit were covered in a series of talks by eminent professionals.

Mark your calendars for 2023's most anticipated event!

We are pleased to announce the dates of the 10th International Conference on Stroke and Neurological Disorder, which will take place in London UK on October 16–17, 2023. This announcement comes as a result of the positive response and feedback we have received from participants and supporters of Neurological Disorder 2023. 'Advances in diagnostics for Stroke and Neurological disorder' is the topic.

Here are a few of our conference photos:

In order to communicate and exchange knowledge, this conference's major goal is to politely invite our honourable to the next "6th International Congress on Stroke Summit and Health Safety," which will be place on October 16–17, 2023 in Vienna, Austria.

The Stroke Summit 2023 featured a collection of world-class speakers who enlightened the audience with their insights into the Stroke Summit and Health Safety.

Being experts in stroke summit and health safety, we hope that this platform will impart knowledge and fresh updates by undergoing with the various interactive sessions to promote the exchange of novel ideas in the field of stroke summit and health safety, in that all the session talks are regarded as great talks that make the attendees, exhibitors, collaborators, and other speakers feel so much interesting.

We would like to invite you to participate in Stroke Summit 2023 as an international organising committee member, speaker, keynote speaker, young research forum participant, sponsor, exhibitor, etc. We want to provide a top-notch programme that covers the whole range of research and advances in the field of stroke summits and shares cross-cultural experiences of different philosophies and approaches.

Stroke Summit 2023 will focus on creating a clear visual definition through workshops, exhibitions, oral presentations, poster presentations, networking events, and other activities.

Stroke Summit 2023 was a huge success thanks to the tremendous support we received, and we are hoping for even more from the healthcare industry, young researchers, students, delegates, directors, and other health-related businesses. Please join us in Vienna, Austria on October 16–17, 2023 for Stroke Summit 2023 so we can make it the most successful event of the year.

Help our team in making Stroke Summit 2023 a great success by coming to this stunning Swiss city with us.


Sharley Lopez || Program Manager

Stroke Summit 2023


To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 16-17, 2023
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View

Media Partners